IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1167/iovs.07-1425 on February 8, 2008
 (Investigative Ophthalmology and Visual Science. 2008;49:1924-1931.)
© 2008 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.07-1425
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
iovs.07-1425v1
49/5/1924    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Kang, J. H.
Right arrow Articles by Pasquale, L. R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kang, J. H.
Right arrow Articles by Pasquale, L. R.

Caffeine Consumption and the Risk of Primary Open-Angle Glaucoma: A Prospective Cohort Study

Jae Hee Kang,1 Walter C. Willett,1,2,3 Bernard A. Rosner,1,4 Susan E. Hankinson,1,3 and Louis R. Pasquale5

1From the Channing Laboratory, Department of Medicine, Brigham & Women’s Hospital and Harvard Medical School, Boston, Massachusetts; 2the Departments of Nutrition, 3Epidemiology, and 4Biostatistics, Harvard School of Public Health, Boston, Massachusetts; and the 5Glaucoma Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts.

PURPOSE. To investigate whether caffeine, which transiently increases intraocular pressure (IOP) is associated with the risk of primary open-angle glaucoma (POAG).

METHODS. A total of 79,120 women from 1980 to 2004 and 42,052 men from 1986 to 2004, who were 40+ years of age, did not have POAG, and reported undergoing eye examinations, were observed. Information on caffeine consumption, potential confounders, and POAG diagnoses were repeatedly updated in validated follow-up questionnaires. One thousand eleven incident POAG cases were confirmed with medical record review. Cohort-specific and pooled analyses across cohorts were conducted to calculate multivariate rate ratios (RRs).

RESULTS. Compared with daily intake of less than 150 mg, the pooled multivariate RRs were 1.05 (95% confidence interval [CI], 0.89–1.25) for consumption of 150 to 299 mg/d, 1.19 (95% CI, 0.99–1.43) for 300 to 449 mg/d, 1.13 (95% CI, 0.89–1.43) for 450 to 559 mg/d, and 1.17 (95% CI, 0.90–1.53) for 600+ mg/d (P for trend = 0.11). However, for consumption of five or more cups of caffeinated coffee daily, the RR was 1.61 (95% CI, 1.00–2.59; P for trend = 0.02); tea or caffeinated cola intake were not associated with risk. Greater caffeine intake was more adversely associated with POAG among those reporting a family history of glaucoma, particularly in relation to POAG with elevated IOP (P for trend = 0.0009; P interaction = 0.04).

CONCLUSIONS. Overall caffeine intake was not associated with increased risk of POAG. However, in secondary analyses, caffeine appeared to elevate risk of high-tension POAG among those with a family history of glaucoma. This result may be due to chance, but warrants further study.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Association for Research in Vision and Ophthalmology